|
|
Insulin Resistance - Research News and Information
Saturday, January 10, 2009
Definition of 'Insulin Resistance'Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. It can be caused by the presence of INSULIN ANTIBODIES or the abnormalities in insulin receptors (RECEPTOR, INSULIN) on target cell surfaces. It is often associated with OBESITY; DIABETIC KETOACIDOSIS; INFECTION; and certain rare conditions. (from Stedman, 25th ed) |
Metabolic syndrome: from epidemiology to systems biology.
30 Oct 2008
Metabolic syndrome (MetSyn) is a group of metabolic conditions that occur together and promote the development of cardiovascular disease (CVD) and diabetes. Recent genome-wide association studies have identified several novel susceptibility genes ... Read more...
30 Oct 2008
OBJECTIVE: The pathogenesis of nonalcoholic fatty liver disease (NAFLD) is multifactorial, and the presence of insulin resistance is recognized as the pathophysiological hallmark of this condition. Arterial hypertension is referred as an ... Read more...
30 Oct 2008
BACKGROUND: Elevated urinary albumin excretion (UAE) is more frequent in patients with the metabolic syndrome or insulin resistance. Whether UAE predicts the development of diabetes mellitus, independently of the presence or the development of the ... Read more...
Learn Faster Today Improve your study skills
Latest indexed articles for 'Insulin Resistance'
These are the very latest articles for this heading:
- Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
3 Nov 2008 - Metabolic syndrome: from epidemiology to systems biology.
30 Oct 2008 - Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients.
30 Oct 2008 - Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study.
30 Oct 2008 - The ketogenic diet in children with Glut1 deficiency syndrome and epilepsy.
30 Oct 2008 - Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways.
30 Oct 2008 - Diabetes. Paradoxical effects of tightly controlled blood sugar.
15 Oct 2008 - Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.
11 Oct 2008 - [Is there a unique measuring method to assess obesity?]
10 Oct 2008 - Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity.
Oct 2008 - Updating the effects of fatty acids on skeletal muscle.
29 Sep 2008 - Does the hormone of eternal youth protect against nonalcoholic steatohepatitis?
29 Sep 2008 - Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.
29 Sep 2008 - NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and diabetes?
29 Sep 2008 - Renin-angiotensin system blockade and diabetes: moving the adipose organ from the periphery to the center.
29 Sep 2008 - Cardiovascular risk in women with polycystic ovary syndrome.
29 Sep 2008 - Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.
29 Sep 2008 - Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
29 Sep 2008 - Evaluation of antioxidant systems (coenzyme Q10 and total antioxidant capacity) in morbid obesity before and after biliopancreatic diversion.
29 Sep 2008 - Insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome.
29 Sep 2008
See a longer list of these articles.
Technical information about 'Insulin Resistance'
Definition: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. It can be caused by the presence of INSULIN ANTIBODIES or the abnormalities in insulin receptors (RECEPTOR, INSULIN) on target cell surfaces. It is often associated with OBESITY; DIABETIC KETOACIDOSIS; INFECTION; and certain rare conditions. (from Stedman, 25th ed)
Descriptor UI: D007333
Alternative terms: Insulin Resistance; Resistance, Insulin;
Allowable Qualifiers: ethnology; genetics; immunology; physiology; radiation effects;
Tree Number: C18.452.394.968.500; G07.690.320.617;
History Note: 67(64)
Technical Notes: for insulin resistance syndrome X use METABOLIC SYNDROME X